Effect of Traditional Chinese Medicine Combined with Bladder Perfusion with Hydroxycamptothecin on Color Ultrasound and Clinical Efficacy in Patients with Bladder Cancer Surgery

Table 2

Comparison of serum-related factors between the two groups before and after treatment.

Project	Observation group		Control group
	Before treatment	After treatment	Before treatment	After treatment
ICAM-1 (ng/L)	75.98 ± 17.11	35.03 ± 6.22	75.73 ± 17.88	47.14 ± 9.03
E-cadherin (ng/L)	76.90 ± 13.78	37.02 ± 5.34	77.02 ± 14.01	64.22 ± 5.52
CAM (ng/L)	21.54 ± 3.85	71.30 ± 13.64	21.67 ± 4.12	38.71 ± 8.09
FGF (pg/L)	26.14 ± 6.72	7.73 ± 2.75	26.34 ± 7.00	13.66 ± 3.23
VEGF-a (μg/L)	196.32 ± 26.24	82.37 ± 5.07	197.21 ± 27.33	162.87 ± 14.28
VEGF-b (μg/L)	126.45 ± 16.02	105.98 ± 12.73	126.08 ± 16.21	65.63 ± 3.79
VEGF-c (μg/L)	151.35 ± 13.03	123.96 ± 7.33	151.12 ± 13.22	71.99 ± 6.93

versus after treatment; versus the control group.